APA (7th ed.) Citation

P, I., P, S., J, O., S, S., S, U., S, M., . . . N, P. (2021). Immunogenicity and Safety of an Intradermal BNT162b2 mRNA Vaccine Booster after Two Doses of Inactivated SARS-CoV-2 Vaccine in Healthy Population. Vaccines, 9(12), . https://doi.org/10.3390/vaccines9121375

Chicago Style (17th ed.) Citation

P, Intapiboon, et al. "Immunogenicity and Safety of an Intradermal BNT162b2 MRNA Vaccine Booster After Two Doses of Inactivated SARS-CoV-2 Vaccine in Healthy Population." Vaccines 9, no. 12 (2021). https://doi.org/10.3390/vaccines9121375.

MLA (9th ed.) Citation

P, Intapiboon, et al. "Immunogenicity and Safety of an Intradermal BNT162b2 MRNA Vaccine Booster After Two Doses of Inactivated SARS-CoV-2 Vaccine in Healthy Population." Vaccines, vol. 9, no. 12, 2021, https://doi.org/10.3390/vaccines9121375.